Company intelligence / Profile preview

Euclid Systems

Sterling / Herndon, Virginia, United Stateseuclidlenses.com ↗

Ownership: Private
Employees: ~106
Development stage: Commercial

Overview

Euclid’s orthokeratology lenses are FDA-approved and commercially available globally with proven efficacy in myopia management. The company’s sustained-release ophthalmic drug delivery system for glaucoma has entered pre-clinical/clinical collaboration with Ora Inc., but no late-stage clinical results are publicly available

Therapeutic areas: Ophthalmology
Modalities: DeviceBiologicDrug delivery system
Industry: Biotech

Partnerships

Ora Inc. (ophthalmic product development partner)

Beyond the preview

Go deeper on Euclid Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Euclid Systems.

Explore the full profile